about
Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis StudyThe causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization studyStability of normative data for the SF-36: results of a three-year prospective study in middle-aged Canadians.The association between body mass index and health-related quality of life: data from CaMos, a stratified population study.Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.Changes in body mass index in Canadians over a five-year period: results of a prospective, population-based study.Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosisCalcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos).Patterns and predictors of sitting time over ten years in a large population-based Canadian sample: Findings from the Canadian Multicentre Osteoporosis Study (CaMos).Densitometer-Specific Differences in the Correlation Between Body Mass Index and Lumbar Spine Trabecular Bone Score.Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality.Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos).The association between sclerostin and incident type 2 diabetes risk: a cohort study.Osteoporotic fractures and obesity affect frailty progression: a longitudinal analysis of the Canadian multicentre osteoporosis study.Dietary patterns in men and women are simultaneously determinants of altered glucose metabolism and bone metabolism.The natural progression of health-related quality of life: results of a five-year prospective study of SF-36 scores in a normative population.Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function.Adult Premenopausal Bone Health Related to Reproductive Characteristics-Population-Based Data from the Canadian Multicentre Osteoporosis Study (CaMos).Women's Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos).Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatmentCharacteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markersPrevalence of and factors associated with glucosamine use in CanadaRisk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos)The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos)The Influence of Osteoporotic Fractures on Health-Related Quality of Life in Community-Dwelling Men and Women across CanadaThe Sustainability of a Workplace Wellness Program That Incorporates Gamification Principles: Participant Engagement and Health Benefits After 2 Years
P50
Q28363574-0241209E-98D8-475A-9A3B-1D35C0CE5368Q28544415-B08A1E7C-2013-4291-8165-50968C1AFCEEQ30970821-C7849AFF-5DEC-43CD-AA3D-D3FCF7459D96Q31134118-04BCD90E-AEEF-4E25-BB05-D090ABAA207DQ31805081-164FAA81-750C-4DCB-8C1B-24011BB745F3Q33290336-691FAFC7-BB1C-4FCF-B3F9-AD37B6E2005BQ33586362-B4F3FDB6-E1F2-4C28-B389-926C3944D5FDQ37395875-32BE3348-AB06-4CCC-86E9-BB7D7185847FQ37625779-39FDF6D0-64A5-4C9C-938D-CCF6E648DFE1Q38407179-7AFAB274-6B3C-4EC7-B6FA-FF6BCB4D0766Q38931635-9382D6CA-9E2F-41D7-B3E8-5C0C1CDFEFD0Q40116921-38BB2A2F-52A7-4969-BE64-184DA6F2E36FQ40379709-6DC3A86E-F9B3-4161-885C-08A0A4027216Q47204378-31FCAAD6-BCB0-4A47-B189-9B8D38FAC43CQ50687322-F0635DBF-CB40-4A27-834A-2BF0B01C75BAQ53000735-A599845A-A00A-42FE-93D5-8BE05077BCF2Q54889121-19E04B36-76EB-4929-B08A-DC578BB9828AQ55241094-EEDC2308-7F97-42C6-BB73-1DFBB5EB5CBAQ55689194-9A741FCC-08FB-4694-9355-3569A2A217CBQ57711656-7C8904AC-652E-46A7-BCC6-18F5897A58EBQ57777448-873BD18D-087F-4538-B078-8A7190E9C817Q57777479-B70815D8-FC2D-4C43-A636-F39A3193F3EBQ57777486-5BAAFC7C-57C5-476B-A815-338CDDFD1D7CQ57777493-97B1455F-DBE8-4C4B-81DC-E5DA21204577Q57777500-F3DE2F61-94F2-45C1-870B-060D6A100AF5Q91145529-0E72FBDC-E5C4-403D-B1F5-3D3169F1007B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Claudie Berger
@ast
Claudie Berger
@en
Claudie Berger
@es
Claudie Berger
@nl
Claudie Berger
@sl
type
label
Claudie Berger
@ast
Claudie Berger
@en
Claudie Berger
@es
Claudie Berger
@nl
Claudie Berger
@sl
prefLabel
Claudie Berger
@ast
Claudie Berger
@en
Claudie Berger
@es
Claudie Berger
@nl
Claudie Berger
@sl
P106
P31
P496
0000-0002-5499-2661